Abstract
Key points
Determining the signalling cascade of epithelial repair, using murine gastric organoids, allows definition of regulatory processes intrinsic to epithelial cells, at the same time as validating and dissecting the signalling cascade with more precision than is possible in vivo
Following single cell damage, intracellular calcium selectively increases within cells adjacent to the damage site and is essential for promoting repair.
Trefoil factor 2 (TFF2) acts via chemokine C‐X‐C receptor 4 and epidermal growth factor receptor signalling, including extracellular signal‐regulated kinase activation, to drive calcium mobilization and promote gastric repair.
Sodium hydrogen exchanger 2, although essential for repair, acts downstream of TFF2 and calcium mobilization.
Abstract
The gastric mucosa of the stomach is continually exposed to environmental and physiological stress factors that can cause local epithelial damage. Although much is known about the complex nature of gastric wound repair, the stepwise process that characterizes epithelial restitution remains poorly defined. The present study aimed to determine the effectors that drive gastric epithelial repair using a reductionist culture model. To determine the role of trefoil factor 2 (TFF2) and intracellular calcium (Ca2+) mobilization in gastric restitution, gastric organoids were derived from TFF2 knockout (KO) mice and yellow Cameleon‐Nano15 (fluorescent calcium reporter) transgenic mice, respectively. Inhibitors and recombinant protein were used to determine the upstream and downstream effectors of gastric restitution following photodamage (PD) to single cells within the gastric organoids. Single cell PD resulted in parallel events of dead cell exfoliation and migration of intact neighbouring cells to restore a continuous epithelium in the damage site. Under normal conditions following PD, Ca2+ levels increased within neighbour migrating cells, peaking at ∼1 min, suggesting localized Ca2+ mobilization at the site of cell protrusion/migration. TFF2 KO organoids exhibit delayed repair; however, this delay can be rescued by the addition of exogenous TFF2. Inhibition of epidermal growth factor receptor (EGFR), extracellular signal‐regulated kinase (ERK)1/2 or a TFF2 receptor, chemokine C‐X‐C receptor 4 (CXCR4), resulted in significant delay and dampened Ca2+ mobilization. Inhibition of sodium hydrogen exchanger 2 (NHE2) caused significant delay but did not affect Ca2+ mobilization. A similar delay was observed in NHE2 KO organoids. In TFF2 KO gastric organoids, the addition of exogenous TFF2 in the presence of EGFR or CXCR4 inhibition was unable to rescue repair. The present study demonstrates that intracellular Ca2+ mobilization occurs within gastric epithelial cells adjacent to the damage site to promote repair by mechanisms that involve TFF2 signalling via CXCR4, as well as activation of EGFR and ERK1/2. Furthermore NHE2 is shown to be important for efficient repair and to operate via a mechanism either downstream or independent of calcium mobilization.
Keywords: epithelia, repair, gastric, TFF2, NHE2, calcium, EGFR, signaling, CXCR4
Key points
Determining the signalling cascade of epithelial repair, using murine gastric organoids, allows definition of regulatory processes intrinsic to epithelial cells, at the same time as validating and dissecting the signalling cascade with more precision than is possible in vivo
Following single cell damage, intracellular calcium selectively increases within cells adjacent to the damage site and is essential for promoting repair.
Trefoil factor 2 (TFF2) acts via chemokine C‐X‐C receptor 4 and epidermal growth factor receptor signalling, including extracellular signal‐regulated kinase activation, to drive calcium mobilization and promote gastric repair.
Sodium hydrogen exchanger 2, although essential for repair, acts downstream of TFF2 and calcium mobilization.
Introduction
Gastric epithelial barrier integrity and proper repair of a disrupted barrier are essential functions to sustain this primary barrier that protects the inner body from noxious contents of the stomach (Niv & Banic, 2014). When encountering either small or extensive epithelial damage, cell migration promotes rapid re‐establishment of epithelial integrity as the initial response of epithelial repair. In the presence of more severe damage, this restitution event occurs before regeneration (cell proliferation) or inflammatory responses. During gastric restitution, dead or damaged cells are expelled into the stomach lumen and adjacent viable cells release bioactive peptides that act as motogens to signal cells to cover the denuded mucosa without proliferation (Svanes et al. 1982; Lacy & Ito, 1984). The mechanism of restitution is speculated to be intrinsic to the epithelial cells themselves because the process can be demonstrated in vitro in cell lines (Rutten & Ito, 1983; Svanes et al. 1983; Kim et al. 2012; Wang et al. 2012), although the regulation and co‐ordination of this multicellular process is poorly understood both in vivo and in vitro. Various factors have been shown in vivo and/or in vitro to influence gastric epithelial restitution, including Ca2+, trefoil factor peptides (TFFs) and epidermal growth factor (EGF) (Hansson et al. 1990; Furukawa et al. 1999; Nie et al. 2003; Yang et al. 2006; Xue et al. 2010; Xue et al. 2011; Aihara et al. 2013; Aihara et al. 2018).
Ca2+ is a ubiquitous second messenger that influences multiple cellular processes, including mucus secretion and cell migration in various cell types (Belkacemi et al. 2005; Schreiber, 2005; Wei et al. 2008; Aihara & Montrose, 2014; Xie et al. 2017). In vivo, gastric damage elicits increased intracellular and extracellular Ca2+ (Takeuchi et al. 1985; Koo, 1994; Takeuchi et al. 1999) and both are necessary for proper gastric wound repair (Aihara et al. 2013). Inhibition of intracellular Ca2+ release or uptake significantly prevents cell migration following wounding in cultured rabbit gastric cells (Ranta‐Knuuttila et al. 2002). Although studies indicate the overarching role of endogenous Ca2+ in gastric epithelial repair, little is known about upstream signalling to regulate Ca2+ mobilization.
Another known factor involved in gastric restitution is the motogenic TFF peptide family. TFFs play an important role within the gastrointestinal (GI) mucosal barrier throughout the GI tract (Lefebvre et al. 1993; Nie et al. 2003; Aihara et al. 2017). In epithelial cell culture models, TFFs have been shown to promote cell migratory and anti‐apoptotic activities (Kinoshita et al. 2000; Taupin & Podolsky, 2003; Hoffmann, 2005), therefore identifying potential roles in mediating mucosal repair. In the stomach of both rodents and humans, TFF2 is abundantly secreted from the stomach mucous neck cells (Hoffmann, 2005; Aihara et al. 2017). TFF2 deficient (TFF2−/−) mice exhibit delayed gastric repair in vivo (Xue et al. 2010; Xue et al. 2011; Aihara et al. 2016); functional assays suggest that C‐X‐C chemokine receptor 4 (CXCR4) acts as a TFF receptor both in vitro and in vivo (Farrell et al. 2002; Dubeykovskaya et al. 2009; Xue et al. 2011). During healing, in vivo epithelial levels of CXCR4 and TFF2 are increased and the addition of exogenous TFF accelerates the healing process (Poulsen et al. 1999; Xu et al. 2013). TFF2 is also increased in response to Helicobacter pylori infection or severe damage caused by repetitive administration of non‐steroidal anti‐inflammatory drugs and such TFF2 upregulation can precede changes in other growth factors, including EGF (Konturek et al. 1998; Chen et al. 2018).
EGF is another peptide produced by the gastric mucosa (Wright et al. 1990) and EGF receptor (EGFR) is present in gastric epithelial cells (Mori et al. 1987; Menard & Pothier, 1991; Chen et al. 2001). EGF stimulates gastric epithelial cell migration and accelerates wound healing acting via EGFR and extracellular signal‐regulated kinase (ERK)1/2 signalling in both in vivo and in vitro models (Tarnawski & Jones, 1998; LI et al. 2003; Tarnawski & Ahluwalia, 2012). There is a potential link between TFF2/CXCR4 and EGFR. In gastric cancer cell lines, CXCR4‐EGFR cross‐talk has been shown to promote cell migration (Guo et al. 2007; Cheng et al. 2017). Additionally, it has also been reported that TFF2 can trigger phosphorylation of EGFR in HT29 colon cancer cells (Kinoshita et al. 2000; Rodrigues et al. 2003; Kosriwong et al. 2011). However, it is not known whether such interactions between TFF2/CXCR4 and EGFR occur outside the setting of cancer cell lines.
Evaluating the epithelial signalling cascade associated with gastric restitution in vivo is difficult. Only a limited number of inhibitors and agonists are suitable for in vivo studies, and the tools for manipulating and monitoring intracellular calcium are less precise in vivo. The organoid culture system allows for the growth and differentiation of primary, normal epithelial cells from mouse tissue (Bartfeld et al. 2015; Schlaermann et al. 2016; Aihara et al. 2018). Gastric organoids contain all epithelial cell types of native tissues (Bartfeld et al. 2015; Schumacher et al. 2015a). We have previously shown gastric organoids provide a unique reductionist model system for examining the molecular mechanisms of restitution in the gastric epithelium (Aihara et al. 2018). Using gastric organoids from normal and mutant mice, we aim to evaluate involvement of TFF2, CXCR4 and EGFR in calcium‐dependent restitution of gastric damage. The results of the present study demonstrate that a novel convergence of the TFF2, EGFR and Ca2+ signalling pathways is essential for gastric epithelial restitution.
Methods
Ethical approval
All animal procedures were approved by the Institutional Animal Care and Use Committee of the University of Cincinnati (protocol 04‐03‐08‐01). The investigators’ work complies with the ethical principles under which the Journal of Physiology operates, as described in Grundy (2012).
Animal husbandry
Experiments used C57BL/6J mice (IMSR catalogue no. JAX:000664, RRID:IMSR_JAX:000664), in‐house bred TFF2 knockout (KO) (backcrossed onto a C57BL/6 background until >90% of genomic microsatellite markers were from C57BL/6J) mice (Xue et al. 2011), in‐bred sodium hydrogen exchanger 2 (NHE2) KO (FVB/N background) mice (Xue et al. 2011) or transgenic mice (C57BL/6 background) expressing the yellow Cameleon‐Nano15 (YC‐Nano) Ca2+ sensor fluorescent proteins (Oshima et al. 2014). We are grateful to Dr Y. Oshima for supplying the animals from the YC‐Nano colony. For experiments examining TFF2 KO (–/–) and NHE2 KO (–/–) genotypes, wild‐type (WT) controls were composed of +/+ genotypes from the same colony. Pups were genotyped by genomic PCR as described previously (Schultheis et al. 1998; Bell et al. 1999; Farrell et al. 2002) and male and female mice were used for experimentation at 2–4 months of age. Animals were given standard rodent chow diet and water, both available ad libitum.
Primary culture of gastric organoids
Gastric organoids were generated from mouse gastric corpus as described previously (Mahe et al. 2013; Schumacher et al. 2015a; Engevik et al. 2018). Mice were killed by isoflurane inhalation, immediately followed by cervical dislocation. Isolated gastric epithelium from the corpus was cultured in Matrigel (Corning, New York, NY, USA) diluted 1:1 in Dulbecco's phosphate‐buffered saline without Ca2+ and Mg2+ in an eight‐well or two‐well Lab‐Tek chamber with coverglass (Thermo Scientific, Waltham, MSA, USA) for growth of gastric organoids. Gastric organoids were cultured in a 5% CO2 incubator at 37°C for 3–4 days prior to the experiments.
Induction of two‐photon laser‐induced photodamage
Experiments were performed in organoid culture medium under conditions of 5% CO2/37°C in a microscope incubation chamber (PeCon, Erbach, Germany) on an inverted confocal microscope (LSM 510 NLO; Carl Zeiss, Oberkochen, Germany) and imaged with a C‐Achroplan NIR 40× objective lens. In some experiments, gastric organoids were pre‐incubated for 30 min with the DNA stain Hoechst 33342 (10 μg mL–1; Invitrogen, Carlsbad, CA, USA) to visualize cellular nuclei. In experiments intended for analysis of damage area and cell exfoliation in YC‐Nano gastric organoids, images of Hoechst 33342 (titanium‐sapphire laser; Ti‐Sa; excitation 730 nm, emission 435–485 nm) and YFP (excitation 514 nm, emission 535–590 nm) in the gastric organoid were collected simultaneously with transmitted light and a confocal reflectance image (reflecting 730 nm light to show cell/tissue structure). In TFF2 and NHE2 WT and KO gastric organoids, images of Hoechst 33342 were collected simultaneously with transmitted light and confocal reflectance images, using the wavelengths reported above. For assessing intracellular Ca2+ changes in YC‐Nano gastric organoids, images of YFP‐Förster resonance energy transfer (FRET) (Ti‐Sa; excitation 840 nm, emission 535–590 nm) and CFP (Ti‐Sa; excitation 840 nm, emission 500–530 nm) were collected simultaneously with a transmitted light image. Wavelength selections for Ca2+ imaging were guided by previous work with YC sensors (Horikawa et al. 2010; Oshima et al. 2014). In all photodamage experiments, after collecting a set of control images, a small rectangular region (∼5 μm2) of a single cell was repetitively scanned at high Ti‐Sa laser power (730 or 840 nm: 630 mW average) for 500 iterations (requiring ∼3 s).
Experiments examined gastric organoids embedded in Matrigel, located ∼100–300 μm from the cover glass. In some cases, BAPTA/AM (50 μm; Calbiochem, San Diego, CA, USA) was applied to medium and incubated for at least 30 min prior to experiments. Inhibitors were pre‐incubated at least 1 h prior to experimentation to ensure equilibration in Matrigel, and were kept in the medium during experiments. Inhibitory reagents included: AMD3100 (1 μm; Sigma, St Louis, MO, USA), AG1478 (200 nm; Cayman Chemical Company, Ann Arbor, MI, USA), FR180204 (10 μm; Tocris Bioscience, St Louis, MO, USA) and Hoechst 694 (100 μm; a gift from Dr H. J. Lang, Sanofi‐Aventis, Frankfurt, Germany). The final DMSO concentration in the experiments was <0.1%. Solvent control groups contained 0.1% DMSO added to medium. Concentrations were determined based upon prior in vitro studies (Chen et al. 2002; Hurst et al. 2008; Aihara et al. 2018) or were shown in preliminary experiments to have no observed significant toxicity in intact organoids, as measured by changes in epithelial permeability or cell death (data not shown). Vehicle control groups contained either 0.1% DMSO, ddH2O or dPBS added to the medium; vehicle was dependent on the solution that the inhibitors used were constituted in.
Damage‐repair cycle was measured independently once per gastric organoid and the outcomes from at least four different gastric organoids (derived from at least three animals) were compiled for each experimental protocol.
Microinjection
For rescue experiments in TFF2 and NHE2 KO gastric organoids, recombinant human TFF2 (rTFF2; 40 μm stock; R&D Systems, Minneapolis, MN, USA) was microinjected as described previously (Engevik et al. 2018). Gastric organoids (∼400–500 μm in diameter) were injected with 9 nL of rTFF2 40 μm stock for an estimated final rTFF2 concentration of 400 nm. In rescue experiments utilizing inhibitors, rTFF2 was microinjected following 1 h of pre‐incubation with inhibitors. Control vehicle TFF2 KO or NHE2 KO gastric organoids were microinjected with 9 nL of dPBS.
Image analysis
Damaged area (units of μm2) was quantified from the time course of images as described previously (Xue et al. 2010; Xue et al. 2011; Aihara et al. 2013; Aihara et al. 2018) using ImageJ (NIH, Bethesda, MD, USA; RRID:SCR_003070) and/or Metamorph, version 6.3 (Molecular Devices, Sunnyvale, CA, USA; RRID:SCR_002368). The damaged area was measured as the region of cellular loss of YFP fluorescence in YC‐Nano gastric organoids. In each experiment of YC‐Nano gastric organoids, we determined the time point displaying maximal damage area and estimated rates of epithelial restitution starting from this time with a single exponential curve fit to the size of damage area over time (Xue et al. 2010; Aihara et al. 2018). Best fit values of the rate constant were used as estimates of the rate of repair (units of min−1). Additionally, movement of nuclei of the damaged cell was traced and exfoliation (units of μm) was measured as the maximum distance of the dead cell nuclear movement at 20 min following photodamage. This time point was selected because it allowed for observation of delayed exfoliation after the addition of inhibitors. Changes in intracellular Ca2+ were measured as FRET/CFP ratio using YC‐Nano gastric organoids. Background images were subtracted from FRET‐YFP and CFP images, the resultant images were divided on a pixel‐by‐pixel basis to calculate the FRET/CFP ratio image. All time course ratio images were then normalized to the averaged pre‐damage baseline images. Regions of interest were determined by transmitted light and 514 nm excited YFP images to define cellular structures for whole cell and lateral region measurements.
Statistical analysis
All values are reported as the mean ± SEM from ‘n’ organoid experiments. Statistical significance was determined using an unpaired Student's t test or one‐way ANOVA with Dunnett's multiple comparison post hoc test. P < 0.05 was considered statistically significant.
Results
Organoids as a model of gastric restitution
Our laboratory has previously used two‐photon photodamage in vivo and in vitro as a method for targeting individual gastric cells (Xue et al. 2010; Xue et al. 2011; Aihara et al. 2013; Aihara et al. 2018) and optically monitoring repair by measuring cell exfoliation and/or the restoration of an intact epithelium caused by migration of neighbouring cells. Recently, we have introduced this approach to gastric organoids (Aihara et al. 2018). In YC‐Nano gastric organoids, localized photodamage to part of a single cell nucleus (stained by Hoechst 33342) caused prompt loss of cytosolic YFP fluorescence (Fig. 1 A). Over time, this damage area diminished as neighbouring cells migrated into the damaged region (Fig. 1 A). Consistent with our recent findings (Aihara et al. 2018), both exfoliation of damaged cell(s) and closure of damaged area are essential for complete repair (Aihara et al. 2018). As described in the Methods, these parallel events can be quantified by measuring the damage area size and/or the distance of the damaged cell nuclei movement (exfoliation) over time (n = 7) (Fig. 1 B). Within ∼10 min, the damage area repairs fully (rate of repair 0.42 ± 0.07 min−1, n = 7) and maximal nucleus exfoliation is observed (exfoliation distance 9.17 ± 1.45 μm, n = 7). The results demonstrate that restitution of the gastric organoid is completed promptly following single cell damage and that multiple measurements can report the progression of this event.
Figure 1. Assessment of repair in photodamage organoid model.

A, top: series of confocal images of YC‐Nano gastric organoid with Hoechst 33342 (red) stained nuclei and gastric organoid structure (YFP, green) before and up to 10 min following single cell photodamage (PD). Single cell PD occurs in the rectangular region (shown in yellow). Below: series of representative illustrations demonstrate measurements taken over time of the damage area and exfoliation of damaged nuclei. Following PD, the damaged cell exfoliates into the lumen coinciding with the closure of damaged area by neighbouring cells filling in the gap left by the departing cell. B, measurement of repair based on damage area (black) and exfoliation (grey) in YC‐Nano gastric organoids following PD at t = 0 min (n = 7).
Calcium is required for epithelial wound repair in gastric organoids
To assess intracellular Ca2+ mobilization during the epithelial repair process, gastric organoids were generated from transgenic YC‐Nano mice that ubiquitously express a sensitive fluorescent Ca2+ reporter (Oshima et al. 2014), allowing the use of FRET to measure intracellular Ca2+ via ratiometric imaging. Based upon transmitted light and YFP images, cellular boundaries were determined and used for assessment of Ca2+ mobilization within intact cells (Fig. 2 A). Upon photodamage to single cells in YC‐Nano organoids (Fig. 1), cells adjacent to the damage site demonstrate Ca2+ mobilization as indicated by the FRET/CFP ratio (Fig. 2 B, neighbour). Ca2+ mobilization peaked at 0.75 ± 0.30 min and dissipated by 4.4 ± 1.0 min (n = 7). As shown in Fig. 2 B, maximal Ca2+ mobilization was greater within the cells directly neighbouring the damage site vs. cells one or two cell positions away from the damage site (P < 0.05). We also tested for subcellular heterogeneity of Ca2+ mobilization within the cells neighbouring the damage. In addition to the whole cell measurement shown in Fig. 2 B, the subcellular lateral membrane region directly adjacent to the damage site was measured separately to assess changes in the FRET/CFP ratio (Fig. 2 C). In cells neighbouring the damage, Ca2+ within the lateral membrane region mobilized with a similar time course as the whole cell (Fig. 2 D). However, the lateral membrane region showed a significantly greater maximal FRET/CFP ratio change (1.43 ± 0.04, n = 4) vs. the whole cell measurement (1.18 ± 0.07, n = 4, P < 0.05). Therefore, the lateral membrane region was measured routinely as a more sensitive indicator of Ca2+ mobilization in all subsequent experiments.
Figure 2. Comparison of intracellular calcium mobilization in cells near the site of damage.

Fluorescence of YC‐Nano gastric organoids imaged over time, before and after photodamage (PD). In time courses, PD occurred at t = 0 min. A, confocal FRET (red)/CFP (green) fluorescence merged image of YC‐Nano gastric organoid at t = 4 min after PD. Representative colour outlines refer to the area used to measure whole cellular calcium levels in intact cells adjacent to damage (neighbour, blue), intact cells one cell space away from damage (1 cell away, red) and intact cells two cell spaces away from damage site (two cells away, purple). Both sides of the damage site were measured and averaged. B, time course measurement of the normalized FRET/CFP ratio from the three cellular regions indicated in (A) (n = 4). Cells adjacent to the damage site show the greatest calcium mobilization after damage. C, confocal FRET/CFP ratio fluorescence merged image and FRET/CFP ratio image of YC‐Nano gastric organoid before and 3 min after PD. Representative colour outlines refer to the area used to measure intracellular calcium levels in lateral membrane region in intact cell adjacent to the damage site (red) and intact whole cell adjacent to damage site (blue). D, time course measurement of the normalized FRET/CFP ratio data from regions indicated in (C) (n = 4). The measurement of damage area (grey) is also shown to report time course of repair.
To confirm the importance of intracellular Ca2+ mobilization in gastric restitution, BAPTA/AM was applied 30 min prior to photodamage to chelate intracellular Ca2+ (Fig. 3). BAPTA/AM significantly blocked repair (Fig. 3 A and B); the damage area remaining at 10 min in BAPTA‐treated organoids (76.27 ± 24.79 μm2, n = 4) was significantly larger than in control organoids (2.3 ± 1.7 μm2, n = 4, P < 0.05) and the corresponding repair rate of 0.11 ± 0.04 min−1 for BAPTA‐treated organoids was significantly reduced compared to 0.36 ± 0.04 min−1 as observed in control gastric organoids (both n = 4, P < 0.05). The addition of BAPTA/AM significantly blunted Ca2+ signalling within cells adjacent to the damage site in YC‐Nano organoids, where the control FRET/CFP ratio peak was 1.49 ± 0.04 compared to a FRET/CFP ratio peak of 1.14 ± 0.01 in the presence of BAPTA/AM (both n = 4, P < 0.05) (Fig. 3 C and D). These data indicate that the FRET/CFP ratio measurements reflect intracellular Ca2+ levels because incubation with BAPTA/AM effectively diminishes the mobilization of free Ca2+ after damage. These results further demonstrate that intracellular Ca2+ mobilization is necessary for repair within the gastric organoid model.
Figure 3. Effect of intracellular calcium chelation on repair and calcium mobilization.

Fluorescence of YC‐Nano gastric organoids imaged over time. BAPTA/AM (50 μm) was added to organoid medium 30 min prior to experimentation. In time courses, PD occurred at t = 0 min. A, damage area measured in control (black) and BAPTA/AM supplemented gastric organoids (white) over time (n = 4). B, comparison of the rate of repair between control (black) and BAPTA/AM supplemented gastric organoids (white) (n = 4, * P < 0.05). C, measurement of the normalized FRET/CFP ratio of the lateral membrane region of cells adjacent to the damage site comparing control (black) and BAPTA/AM supplemented gastric organoids (white). D, comparison of the maximum FRET/CFP ratio from (C) between control (black) and BAPTA/AM (white) gastric organoids (n = 4, * P < 0.05).
The TFF2 receptor CXCR4 acts upstream of Ca2+ mobilization and is involved in gastric restitution
Epithelial damage is known to elicit the release of TFF2, which acts via CXCR4 within the gastric epithelium (Xue et al. 2010) and in immune cells (Dubeykovskaya et al. 2009). To determine whether epithelial CXCR4 was involved in gastric organoid restitution, the CXCR4 inhibitor AMD3100 was added to YC‐Nano gastric organoids. At 10 min, control gastric organoids exhibited a 5.8 ± 3.9 μm2 damage area and a repair rate of 0.41 ± 0.05 min−1, whereas organoids treated with 1 μm AMD3100 displayed a 56 ± 18 μm2 damage area and significantly delayed repair rate of 0.20 ± 0.07 min−1 (n = 4, P < 0.05) (Fig. 4 A and B). A parallel examination of Ca2+ mobilization revealed that CXCR4 inhibition significantly blunted Ca2+ mobilization from 1.43 ± 0.04 FRET/CFP ratio peak in control to a 1.17 ± 0.03 FRET/CFP ratio peak in cells adjacent to the damage site (n = 4, P < 0.05) (Fig. 4 C and D). The results indicated that CXCR signalling and CXCR4‐mediated repair involve Ca2+ mobilization.
Figure 4. Effect of CXCR4 inhibition on repair and calcium mobilization.

Fluorescence of YC‐Nano gastric organoids imaged over time. Where indicated, AMD3100 (1 μm) was added to organoid medium 1 h prior to experimentation. In time courses, PD occurred at t = 0 min. A, damage area measured in control (black) and AMD3100 supplemented gastric organoids (white) (n = 4). B, comparison of the rate of repair between control (black) and AMD3100 supplemented gastric organoids (white) (n = 4, * P < 0.05). C, measurement of the normalized FRET/CFP ratio of the lateral membrane region of cells adjacent to the damage site comparing control (black) and AMD3100 supplemented gastric organoids (white). D, comparison of the maximum FRET/CFP ratio from (C) between control (black) and AMD3100 (white) gastric organoids (n = 4, * P < 0.05).
TFF2 action requires CXCR4 and calcium mobilization acting downstream during gastric restitution
Prior data show the close correlation of damage area and dead cell exfoliation as two independent measurements of gastric repair (Aihara et al. 2018). As a result of the lack of intrinsic fluorescence probes, only exfoliation was measured to assess repair in subsequent experiments using TFF2 WT and KO organoids. By contrast to WT organoids, which exhibited an exfoliation distance of 8.81 ± 0.70 μm (n = 7) at 20 min post‐injury, exfoliation was significantly diminished in WT organoids treated with AMD3100 (1.33 ± 0.35 μm, n = 6) or BAPTA/AM (1.52 ± 0.24 μm, n = 4) (P < 0.05) (Fig. 5). Compared to WT, TFF2 KO organoids also exhibited a significant reduction of exfoliation at 2.11 ± 0.27 μm (n = 10, P < 0.05). Treatment of TFF2 KO organoids with AMD3100 (1.33 ± .35 μm, n = 6) or BAPTA/AM (1.31 ± 0.31 μm, n = 4) did not alter the already compromised exfoliation. However, the delayed exfoliation observed in TFF2 KO was rescued by microinjection of exogenous rTFF2 into the organoid lumen (8.55 ± 0.94 μm, n = 10, P < 0.05) (Fig. 5). This rescue was not significantly different regardless of whether exogenous rTFF2 was added to the organoid medium or microinjected (7.96 ± 0.68 μm, n = 4). As a result of limited availability of rTFF2, gastric organoids were microinjected in the present study. Exogenous rTFF2 was unable to rescue the exfoliation in the presence of AMD3100 (2.22 ± 0.29 μm, n = 5) (Fig. 5).
Figure 5. Comparison of exfoliation within WT and TFF2 KO organoids with and without treatments.

Results from WT and TFF2 KO gastric organoids imaging over time, measuring the movement of fluorescent nuclei (Hoechst 33342 stain) after PD. PD occurred at t = 0 min. WT and TFF2 KO gastric organoids were treated with AMD3100 (1 μm) for 1 h or BAPTA/AM (50 μm) for 30 min before PD as indicated. rTFF2 was microinjected into the lumen of organoids 30 min before the study (see Methods). Exfoliation was determined based on the maximum distance of damaged nuclei into gastric organoid lumen over 20 min. Vehicle (WT control, n = 7; TFF2 KO control, n = 10; TFF2 + rTFF2 Control, n = 10); AMD3100 (WT, n = 6; TFF2 KO, n = 6; TFF2 KO + rTFF2, n = 5); BAPTA/AM (WT, n = 4; TFF2 KO, n = 4; TFF2 KO + rTFF2, n = 8). * P < 0.05 vs. WT vehicle, #P < 0.05 vs. rTFF2 treatment in TFF2 KO.
CXCR4 inhibition altered Ca2+ mobilization (as shown in Fig. 3) and separately prevented rTFF2 action during repair, although the link between the two outcomes is unclear. To directly test whether TFF2 action is dependent upon Ca2+ mobilization, BAPTA/AM was added to the media in the presence of gastric organoids microinjected with rTFF2. Incubation with BAPTA/AM prevented the rTFF2 rescue (1.30 ± 0.32 μm, n = 8, P < 0.05) (Fig. 5). These results indicate that TFF2 action requires Ca2+ mobilization to promote the repair process.
EGFR acts upstream of Ca2+ mobilization and is involved in gastric restitution
In renal, ovarian and colonic cancer cells, TFF2 and/or CXCR4 have been shown to interact with or activate EGFR (Rodrigues et al. 2003; Guo et al. 2007; Kosriwong et al. 2011). Because EGFR has been implicated separately in epithelial wound healing (Hansson et al. 1990), YC‐Nano organoids were treated with an EGFR inhibitor (AG1478; 200 nm) to test the role of EGFR in gastric restitution (Fig. 6). At 10 min, compared to control gastric organoids that exhibited a damage area of 1.0 ± 0.5 μm2 and a repair rate of 0.43 ± 0.05 min−1, EGFR inhibition significantly delayed epithelial repair with a damage area of 42 ± 26 μm2 (P < 0.05) and a repair rate of 0.25 ± 0.02 min−1 (P < 0.05 (Fig. 6 A and B). Furthermore, EGFR blockage significantly blunted the maximal FRET/CFP ratio peak from 1.32 ± 0.02 in control to 1.04 ± 0.01 (n = 4, P < 0.05) (Fig. 6 C and D). These results suggest that EGFR promotes Ca2+ mobilization and gastric restitution.
Figure 6. Effect of EGFR inhibition upon repair and calcium mobilization.

Fluorescence of YC‐Nano gastric organoids imaged over time. AG1478 (200 nm) was added to organoid medium 1 h prior to experimentation. In time courses, PD occurred at t = 0 min. A, damage area measured in control (black) and AG1478 supplemented gastric organoids (white) (n = 4). B, comparison of the rate of repair between control (black) and AG1478 supplemented gastric organoids (white) (* P < 0.05).C, measurement of the normalized FRET/CFP ratio of the lateral membrane region of cells adjacent to the damage site comparing control (black) and AG1478 supplemented gastric organoids (white). D, comparison of the maximum FRET/CFP ratio from (C) between control (black) and AG1478 supplemented gastric organoids (white) (n = 4, * P < 0.05).
TFF2 KO organoids were then used to test whether the EGFR is a potential downstream effector of TFF2/CXCR4. The addition of AG1478 caused a significant delay in exfoliation (1.76 ± 0.41 μm vs. 8.18 ± 0.35 μm in control, n = 6, P < 0.05) (Fig. 7). However, in TFF2 KO organoids, the addition of AG1478 (1.56 ± 0.89 μm, n = 5) had no additive effect on exfoliation compared to vehicle (1.56 ± 0.31 μm, n = 8). Furthermore, the addition of rTFF2 significantly rescued exfoliation in TFF2 KO (8.87 ± 0.82 μm, n = 8, P < 0.05). However, in the presence of AG1478, rescue by rTFF2 was significantly prevented (2.30 ± 0.55 μm, n = 5, P < 0.05). Taken together, these results suggest that EGFR acts downstream of TFF2/CXCR4 in the repair pathway. Because both receptors are necessary to stimulate Ca2+ mobilization and promote gastric restitution, these data suggest that both CXCR4 and EGFR may be acting via the same Ca2+ mobilizing signalling pathway during repair.
Figure 7. Comparison of exfoliation within EGFR inhibited WT and TFF2 KO organoids.

Results from imaging of WT and TFF2 KO organoids over time; measuring the movement of fluorescent nuclei (Hoechst 33342 stain) after PD. Some organoids were treated with AG1478 (200 nm) as indicated. rTFF2 was microinjected into the lumen of organoids before the study. Exfoliation was determined based on the maximum distance of damaged nuclei into gastric organoid lumen over 20 min. Vehicle (WT control, n = 6; TFF2 KO control, n = 8; TFF2 KO + rTFF2, n = 8); AG1478 (WT, n = 6; TFF2 KO, n = 5; TFF2 KO + rTFF2, n = 5). * P < 0.05 vs. WT vehicle, #P < 0.05 vs. rTFF2 treatment in TFF2 KO.
ERK1/2 is necessary for the repair process, acting upstream of calcium mobilization
CXCR4 and EGFR both act via ERK1/2 signalling in various systems (LI et al. 2003; Billadeau et al. 2006; Zimmerman et al. 2011). To test for a role of ERK1/2 within our organoid model, an ERK1/2 inhibitor (10 μm FR180204) was added to YC‐Nano gastric organoids. By contrast to control gastric organoids that exhibited a fully repaired space of 0 μm2 damage area at 10 min and a repair rate of 0.45 ± 0.04 min−1, organoids treated with FR180204 displayed a 34.9 ± 2.6 μm2 damage area at 10 min and a repair rate of 0.21 ± 0.03 min−1 (Fig. 8 A and B) (both n = 4, P < 0.05). Examination of Ca2+ mobilization by FRET/CFP ratio in gastric organoids revealed that FR180204 dampened Ca2+ mobilization in the cell adjacent to the damage site (1.13 ± 0.02 compared to control 1.33 ± 0.03, both n = 4, P < 0.05) (Fig. 8 C and D). These results indicate that ERK1/2 operates upstream of Ca2+ mobilization pathways during repair.
Figure 8. Effect of ERK1/2 inhibition on repair and calcium mobilization.

Fluorescence of YC‐Nano gastric organoids imaged over time. Where indicated, FR180204 (10 μm) was added to organoid medium 1 h prior to experimentation. In time courses, PD occurred at t = 0 min. A, damage area measured in control (black) and FR180204 supplemented gastric organoids (white) (n = 4). B, comparison of the rate of repair between control (black) and FR180204 supplemented gastric organoids (white) (* P < 0.05). C, measurement of the normalized FRET/CFP ratio of the lateral membrane region of cells adjacent to the damage site comparing control (black) and FR180204 supplemented gastric organoids (white). D, comparison of the maximum FRET/CFP ratio from (C) between control (black) and FR180204 supplemented gastric organoids (white) (n = 4, * P < 0.05).
NHE2 acts downstream of calcium mobilization in TFF2‐driven repair
NHE2 has been previously implicated as acting downstream of TFF2 action, in an unknown manner, to promote gastric repair in vivo (Xue et al. 2011). To determine whether NHE2 was necessary to repair within the in vitro gastric organoid model and investigate whether it affected Ca2+ mobilization, the selective NHE1/2 inhibitor Hoechst 694 (Hoe 694, 100 μm) was pre‐incubated in YC‐Nano gastric organoids prior to photodamage. At 10 min following damage Hoe 694 delayed epithelial repair, with a damage area of 32.03 ± 7.53 μm2 and a repair rate of 0.28 ± 0.04 min−1 vs. a damage area of 3.50 ± 2 μm2 and a repair rate of 0.49 ± 0.05 min−1 in control (Fig. 9 A and B) (both n = 4, P < 0.05). Interestingly, Hoe 694 did not significantly alter the Ca2+ mobilization following damage(Fig. 9 C and D) (control 1.37 ± 0.04 vs. Hoe 694 1.30 ± 0.02, both n = 4). These results show that, although NHE2 action is important for repair, it does not affect Ca2+ mobilization during the repair process, suggesting that NHE2 acts downstream of Ca2+ mobilization during repair.
Figure 9. Effect of NHE1/2 inhibition and loss of NHE2 function on calcium mobilization and repair.

Fluorescence of YC‐Nano gastric organoids imaged over time in (A) to (D) and cell exfoliation measured over time in (E) to (F). Where indicated, Hoe 694 (100 μm) was added to organoid medium 1 h prior to experimentation. In time courses, PD occurred at t = 0 min. A, damage area measured in YC‐Nano control (black) and Hoe 694 supplemented gastric organoids (white) (n = 4). B, comparison of rate of repair between YC‐Nano control (black) and Hoe 694 supplemented gastric organoids (white) (* P < 0.05). C, measurement of the normalized FRET/CFP ratio of the lateral membrane region of cells adjacent to the damage site comparing control (black) and Hoe 694 supplemented gastric organoids (white). D, comparison of the maximum FRET/CFP ratio from (C) between control (black) and Hoe 694 supplemented gastric organoids (white) (n = 4, * P < 0.05). E, comparison of exfoliation in WT (n = 5) and NHE2 KO vehicle (n = 5) and rTFF2 injected organoids (n = 6) (* P < 0.05). F, comparison of exfoliation in WT and TFF2 KO gastric organoids treated with Hoe 694 and/or microinjection of rTFF2. Vehicle (WT Control, n = 5; TFF2 KO, n = 6; TFF2 KO + rTFF2, n = 4); Hoe 694 (WT, n = 5; TFF2 KO, n = 4; TFF2 KO + rTFF2, n = 4). * P < 0.05 vs. WT vehicle, #P < 0.05 vs. rTFF2 treatment in TFF2 KO.
Consistent with these findings, as well as prior in vivo work (Xue et al. 2011), NHE2 KO gastric organoids exhibited a significantly delayed exfoliation of 4.21 ± 0.66 μm compared to the WT gastric organoid exfoliation of 8.81 ± 0.70 μm (Fig. 9 E) (n = 5, P < 0.05). To confirm that NHE2 acts downstream of TFF2 action during repair, as suggested by the previous in vivo studies (Xue et al. 2011), rTFF2 was microinjected into NHE2 KO organoids and monitored over time. Microinjection of rTFF2 into NHE2 KO organoids did not stimulate exfoliation (4.61 ± 0.41 μm, n = 6, P < 0.05) (Fig. 9 E). To confirm that NHE2 is involved in TFF2‐driven repair, TFF2 KO organoids were used to test whether Hoe 694 would affect rTFF2 rescue action (Fig. 9 F). Similar to earlier results measuring damage area (Fig 9 A), WT control exfoliation (9.66 ± 1.05 μm, n = 5) was significantly inhibited by the addition of Hoe 694 (1.90 ± 0.56 μm, n = 5, P < 0.05). Reduced exfoliation was again observed in TFF2 KO (1.26 ± 0.32 μm, n = 6) and the addition of Hoe 694 did not inhibit exfoliation further (1.33 ± 0.24 μm, n = 4). Microinjection of rTFF2 rescued exfoliation (9.0 ± 0.71 μm, n = 4); however, the presence of Hoe 694 prevented the rescue effect of rTFF2 (1.42 ± 0.23 μm, n = 4, P < 0.05). These data further support NHE2 being necessary for the repair process and as a probable downstream target of TFF2 action during repair.
Discussion
Restitution is the initiating event in epithelial repair and involves cell migration, not proliferation, for the rapid re‐establishment of epithelial integrity following injury. In the present study, we focused upon gastric epithelial restitution in response to microscopic photodamage, using a reductionist gastric epithelium model comprising gastric organoids. This model allows us to investigate the innate epithelial response separate from the complexities of native tissue because the organoid system is devoid of other tissue cell types (immune cells, mesenchymal cells, smooth muscle, neurons, etc.).
The results of the present study provide a deeper validation regarding the gastric organoid model maintaining fidelity for major features of gastric restitution compared to the in vivo photodamage results (Xue et al. 2010; Xue et al. 2011; Demitrack et al. 2012; Aihara et al. 2013; Aihara & Montrose, 2014). We have recently demonstrated that the gastric organoid system is comparable to native tissue in vivo with respect to demonstrating the shedding of dead cells into the gastric lumen with an epithelial repair time course of ∼10 min (Aihara et al. 2018). In the present study, gastric organoids are also found to be similar to native tissue because they demonstrate (i) increased intracellular Ca2+ mobilization during repair (Aihara et al. 2013); (ii) dependence on TFF2, CXCR4 and NHE2 for repair (Xue et al. 2010; Xue et al. 2011); and (iii) placement of NHE2 as the most downstream effector identified in the TFF2/CXCR4 repair pathway (Xue et al. 2011). These results identify features intrinsic to the epithelium, which operate in the absence of normal tissue architecture and accessory cell types. Furthermore, the present study delineates the relationship among known components of wound healing and links them within a signalling pathway, using an in vitro culture that more closely reflects native tissue. Through the gastric organoid system, we have been able to determine upstream and downstream effectors of gastric restitution, which had been previously difficult to achieve in vivo. The present study now identifies specific pathways that can be tested in vivo in future investigations.
The gastric organoid system is reported to contain various cell types as seen in vivo, as well as to exhibit responses similar to infection and damage in native tissue (Schumacher et al. 2015a; Schumacher et al. 2015b; Aihara et al. 2018). Despite having a diversity of cell types within the organoid system, damage repair has not been shown to be a heterogenous response either in the present study or previous work (Aihara et al. 2018). Different cell types were not morphologically identifiable and no criteria were applied during the selection of cells to undergo damage, beyond their physical location in a site amenable to optical tracking of repair and cell extrusion. This observed homogeneity in the cellular response to damage suggests that this function is not dependent on cell type but, instead, comprises a highly conserved response to prevent the loss of epithelial barrier function.
The present study is the first to utilize the genetically encoded YC‐Nano Ca2+ reporter in studies of gastric tissues. Previously, our laboratory used YC 3.0 transgenic mice to show that endogenous Ca2+ mobilization is required for proper wound repair in vivo (Aihara et al. 2013). The gastric organoid model, utilizing the more sensitive YC‐Nano Ca2+ indicator, offers a significant improvement over in vivo techniques because Ca2+ levels in individual cells can be resolved using a greater dynamic range of FRET/CFP ratio change, and a brighter overall signal (data not shown). Using YC‐Nano gastric organoids, we show that intracellular Ca2+ mobilization is a downstream event stimulated by TFF2, CXCR4 and EGFR activity during the repair process. Using the enhanced imaging resolution of organoids, we determined that Ca2+ mobilization was largely restricted to the cells directly adjacent to the wound site. Furthermore, within these cells, the lateral membrane region adjacent to damage was a proverbial hot spot of Ca2+ mobilization. Recently, we demonstrated that actin increases in the lateral membrane to initiate restitution and that this action requires calcium and CXCR4 (Aihara et al. 2018). We speculate that this subcellular region may be a localized area optimized to stimulate Ca2+‐dependent biochemical events, such as actin dynamics, in the part of the cell mediating cell motility. Although Ca2+ mobilization is demonstrated to be important in repair, further studies are necessary to understand the source of this raised cytosolic Ca2+, as well as whether it is the direct result of Ca2+ released from intracellular stores and/or from activation of Ca2+ flux across the plasma membrane.
Several lines of evidence support a link between TFF2 and Ca2+ mobilization. In Jurkat cells, TFF2 activates Ca2+ signalling via the CXCR4 chemokine receptor (Dubeykovskaya et al. 2009). In colonic Caco‐2 epithelial cells, activation of CXCR4 stimulated the release of intracellular Ca2+ and enhanced intestinal epithelial restitution via reorganization of the actin cytoskeleton (Agle et al. 2010). It has also been reported that gastric epithelial damage is associated with intracellular and extracellular Ca2+ mobilization in vivo and that this flux of Ca2+ is required to mediate tissue repair (Aihara et al. 2013).
Although it has been shown previously in separate studies (and distinct cell types) that TFF can promote Ca2+ mobilization or Ca2+ can modulate repair, the present study is the first to provide direct evidence that causally links and extends these observations. We show that Ca2+ mobilization is required for TFF2‐mediated repair, which occurs via CXCR4. The key observations are that inhibition of CXCR4 impedes Ca2+ mobilization and slows repair in normal tissue, and CXCR4 is also required when exogenous rTFF2 is added to rescue repair in TFF2‐KO cells. Normal repair, rTFF2‐rescued repair and damage‐induced Ca2+ mobilization can all be blocked by the Ca2+ chelator BAPTA/AM. This demonstrates the calcium dependence of the repair process and provides strong evidence indicating that Ca2+ mobilization is an essential downstream effector of TFF2/CXCR4 action during repair.
Evidence obtained outside of the GI tract, as well as studies with GI cancer cell lines, suggests that CXCR4 and EGFR may act via the same repair pathway, introducing the concept of CXCR4 activating EGFR during the repair process (Billadeau et al. 2006; Guo et al. 2007; Cheng et al. 2017). There is also evidence suggesting the ability of TFF2 to either directly or indirectly activate EGFR in colonic cancer cells during cell invasion (Rodrigues et al. 2003; Kosriwong et al. 2011). Furthermore, ERK is an integration point for multiple receptor‐mediated pathways. There is also evidence obtained in vitro indicating that TFF2 treatment causes activation of ERK1/2 via the CXCR4 receptor in gastric cancer epithelial AGS cells and lymphocytic cancer Jurak cells (Dubeykovskaya et al. 2009), suggesting that TFF2 activation of CXCR4 mediates ERK signalling. Studies in Caco2 cells show that ERK phosphorylation during repair is attenuated by EGFR inhibition, indicating that ERK phosphorylation is triggered via a pathway involving EGFR activation (Buffin‐Meyer et al. 2007). Stimulation of EGFR and subsequent activation of ERK1/2 have been demonstrated to be present in healing gut mucosa (Hansson et al. 1990), although MEK/ERK signalling is not always essential for restitution (Frey et al. 2004), possibly as a result of to region‐ or tissue‐specific effects. There is additional evidence that ERK1/2 activation is primarily responsible for TFF mediated initiation of healing. Yu et al. (2010) reported that TFF2 enhanced cell migration and wound healing in the gastric cell line AGS and rat small intestine cell line IEC‐6 in an ERK1/2 activation‐dependent manner.
Our data suggest that EGFR potentially acts downstream of CXCR4 and as a necessary component during TFF2‐driven repair; however, further research is needed to determine whether this is by transactivation or whether EGFR acts independently of CXCR4. Furthermore, our results indicate that ERK1/2 activity is a necessary component for proper repair in the epithelium, although it has not been formally addressed as to whether phosphorylation of ERK1/2 in this cascade is the direct effect of either CXCR4 or EGFR activation. Our data show that ERK1/2 acts upstream of intracellular Ca2+ mobilization during the repair process. Evidence from previous studies and the current literature suggests that ERK1/2 may be the primary pathway of EGFR action during repair. Future studies are needed to confirm whether ERK is acting in the same pathway as TFF2 (or EGFR) during repair in the gastric epithelium.
Previously, our laboratory has shown that, in vivo, NHE2 is necessary during the repair process and probably acts downstream of TFF2 during repair (Xue et al. 2011). The results of the present study have extended these findings because the addition of exogenous rTFF2 to NHE2 KO organoids did not alter delayed repair, with NHE1/2 inhibition slowing the repair of normal organoids. EGF contribution to restitution has been shown to be mediated in part by stimulation of NHE in gastric epithelial cells (Yanaka et al. 2002). EGF is involved in acute regulation of cytoskeletal elements and NHE activity (Iwatsubo et al. 1989; Ghishan et al. 1992; Furukawa & Okabe, 1997; Furukawa et al. 1999) and the ERK pathway was also shown to be a critical component of NHE activation (Yoo et al. 2011; Muthusamy et al. 2012). We demonstrate that inhibition of NHE2 does not affect Ca2+ mobilization, suggesting that Ca2+ acts upstream of NHE2 or (less probable) that NHE2 action is regulated via a parallel Ca2+ independent pathway. The role of NHE2 in promoting repair remains unknown but, based upon the literature, we hypothesize that NHE2 may regulate actin polymerization during repair and a necessary component for cytoskeletal structural rearrangements during migration (Vexler et al. 1996; Denker & Barber, 2002).
Conclusions
The present study demonstrates that TFF2 acts via CXCR4 and EGFR signalling, including ERK activation, to drive Ca2+ mobilization and promote gastric repair. This work expands upon knowledge concerning the TFF2 signalling pathway (Dubeykovskaya et al. 2009; Xue et al. 2010) and points to TFF2 and its activation of CXCR4 and EGFR as potential targets for promoting restitution. Additionally, these studies validate gastric organoids as a platform for studying repair and identifying potential future therapeutic targets.
Additional information
Competing interests
The authors declare that they have no competing interests.
Author contributions
KAE, EA and MHM were responsible for conceiving the study. KAE and EA were responsible for study methodology. KAE was responsible for formal analysis. KAE, EA, HH and ALM were responsible for conducting investigations. YO and MRF were responsible for study resources. KAE and MHM were responsible for writing the original draft. EA and MHM were responsible for supervision. KAE, EA and MHM were responsible for project administration. KAE, EA, MHM and MRF were responsible for acquisition of funding.
Funding
This work was supported by the National Institutes of Health (NIH) R01DK102551 (MHM), F31DK115126 (KAE) and R01DK095004 (MRF). This project was also supported in part by the NIH P30 DK078392; Live Microscopy Core and DNA Sequencing and Genotyping Core of the Digestive Disease Research Core Center in Cincinnati.
Biography
Kristen Engevik is a PhD candidate at the University of Cincinnati College of Medicine. Kristen's research focuses on investigating the mechanism behind gastric restitution. Her expertise lies in culturing three‐dimensional gastric organoids and the use of two‐photon light microscopy to induce photodamage with respect to examining the pathways involved in gastric repair.

Edited by: Peying Fong & Melanie Gareau
This is an Editor's Choice article from the 15 May 2019 issue.
Linked articles This article is highlighted in a Perspectives article by Cho & Mills and a Journal Club article by Iyengar & Jangra. To read these articles, visit https://doi.org/10.1113/JP278054 and https://doi.org/10.1113/JP278602.
References
- Agle KA, Vongsa RA & Dwinell MB (2010). Calcium mobilization triggered by the chemokine CXCL12 regulates migration in wounded intestinal epithelial monolayers. J Biol Chem 285, 16066–16075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aihara E, Engevik KA & Montrose MH (2017). Trefoil factor peptides and gastrointestinal function. Annu Rev Physiol 79, 357–380. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aihara E, Hentz CL, Korman AM, Perry NP, Prasad V, Shull GE & Montrose MH (2013). In vivo epithelial wound repair requires mobilization of endogenous intracellular and extracellular calcium. J Biol Chem 288, 33585–33597. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aihara E, Matthis AL, Karns RA, Engevik KA, Jiang P, Wang J, Yacyshyn BR & Montrose MH (2016). Epithelial regeneration after gastric ulceration causes prolonged cell‐type alterations. Cell Mol Gastroenterol Hepatol 2, 625–647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aihara E, Medina‐Candelaria NM, Hanyu H, Matthis AL, Engevik KA, Gurniak CB, Witke W, Turner JR, Zhang T & Montrose MH (2018). Cell injury triggers actin polymerization to initiate epithelial restitution. J Cell Sci 131, pii: jcs216317. 10.1242/jcs.216317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aihara E & Montrose MH (2014). Importance of Ca(2+) in gastric epithelial restitution‐new views revealed by real‐time in vivo measurements. Curr Opin Pharmacol 19, 76–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bartfeld S, Bayram T, van de Wetering M, Huch M, Begthel H, Kujala P, Vries R, Peters PJ & Clevers H (2015). In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection. Gastroenterology 148, 126–136 e126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Belkacemi L, Bedard I, Simoneau L & Lafond J (2005). Calcium channels, transporters and exchangers in placenta: a review. Cell Calcium 37, 1–8. [DOI] [PubMed] [Google Scholar]
- Bell SM, Schreiner CM, Schultheis PJ, Miller ML, Evans RL, Vorhees CV, Shull GE & Scott WJ (1999). Targeted disruption of the murine Nhe1 locus induces ataxia, growth retardation, and seizures. Am J Physiol Cell Physiol 276, C788–C795. [DOI] [PubMed] [Google Scholar]
- Billadeau DD, Chatterjee S, Bramati P, Sreekumar R, Shah V, Hedin K & Urrutia R (2006). Characterization of the CXCR4 signaling in pancreatic cancer cells. J Gastrointest Cancer 37, 110–119. [DOI] [PubMed] [Google Scholar]
- Buffin‐Meyer B, Crassous P‐A, Delage C, Denis C, Schaak S & Paris H (2007). EGF receptor transactivation and PI3‐kinase mediate stimulation of ERK by α2A‐adrenoreceptor in intestinal epithelial cells: a role in wound healing. Eur J Pharmacol 574, 85–93. [DOI] [PubMed] [Google Scholar]
- Chen J‐K, Capdevila J & Harris RC (2002). Heparin‐binding EGF‐like growth factor mediates the biological effects of P450 arachidonate epoxygenase metabolites in epithelial cells. Proc Natl Acad Sci U S A 99, 6029–6034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen MC, Goliger J, Bunnett N & Soll AH (2001). Apical and basolateral EGF receptors regulate gastric mucosal paracellular permeability. Am J Physiol Gastrointest Liver Physiol 280, G264–G272. [DOI] [PubMed] [Google Scholar]
- Chen X, Hu Y, Xie Y & Wang Y (2018). High salt diet can down‐regulate TFF2 expression level in gastric mucosa of MGs after H. pylori infection. Microb Pathog 118, 316–321. [DOI] [PubMed] [Google Scholar]
- Cheng Y, Qu J, Che X, Xu L, Song N, Ma Y, Gong J, Qu X & Liu Y (2017). CXCL12/SDF‐1alpha induces migration via SRC‐mediated CXCR4‐EGFR cross‐talk in gastric cancer cells. Oncol Lett 14, 2103–2110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Demitrack ES, Aihara E, Kenny S, Varro A & Montrose MH (2012). Inhibitors of acid secretion can benefit gastric wound repair independent of luminal pH effects on the site of damage. Gut 61, 804–811. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Denker SP & Barber DL (2002). Cell migration requires both ion translocation and cytoskeletal anchoring by the Na‐H exchanger NHE1. J Cell Biol 159, 1087–1096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dubeykovskaya Z, Dubeykovskiy A, Solal‐Cohen J & Wang TC (2009). Secreted trefoil factor 2 activates the CXCR4 receptor in epithelial and lymphocytic cancer cell lines. J Biol Chem 284, 3650–3662. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Engevik KA, Matthis AL, Montrose MH & Aihara E (2018). Organoids as a model to study infectious disease In Host‐Pathogen Interactions, pp. 71–81. Springer, New York, NY, USA. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Farrell JJ, Taupin D, Koh TJ, Chen D, Zhao C‐M, Podolsky DK & Wang TC (2002). TFF2/SP‐deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury. J Clin Invest 109, 193–204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Frey MR, Golovin A & Polk DB (2004). Epidermal growth factor‐stimulated intestinal epithelial cell migration requires Src family kinase‐dependent p38 MAPK signaling. J Biol Chem 279, 44513–44521. [DOI] [PubMed] [Google Scholar]
- Furukawa O, Matsui H, Suzuki N & Okabe S (1999). Epidermal growth factor protects rat epithelial cells against acid‐induced damage through the activation of Na+/H+ exchangers. J Pharmacol Exp Ther 288, 620–626. [PubMed] [Google Scholar]
- Furukawa O & Okabe S (1997). Cytoprotective effect of epidermal growth factor on acid‐ and pepsin‐induced damage to rat gastric epithelial cells: roles of Na+/H+ exchangers. J Gastroenterol Hepatol 12, 353–359. [DOI] [PubMed] [Google Scholar]
- Ghishan FK, Kikuchi K & Riedel B (1992). Epidermal growth factor up‐regulates intestinal Na+/H+ exchange activity. Proc Soc Exp Biol Med 201, 289–295. [DOI] [PubMed] [Google Scholar]
- Grundy D (2015). Principles and standards for reporting animal experiments in The Journal of Physiology and Experimental Physiology. J Physiol 593, 2547–2549. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guo Z, Cai S, Fang R, Chen H, Du J, Tan Y, Ma W, Hu H & Liu Y (2007). The synergistic effects of CXCR4 and EGFR on promoting EGF‐mediated metastasis in ovarian cancer cells. Colloids Surf B 60, 1–6. [DOI] [PubMed] [Google Scholar]
- Hansson HA, Hong L & Helander HF (1990). Changes in gastric EGF, EGF receptors and acidity during healing of gastric ulcer in the rat. Acta Physiol Scand 138, 241–242. [DOI] [PubMed] [Google Scholar]
- Hoffmann W (2005). Trefoil factors TFF (trefoil factor family) peptide‐triggered signals promoting mucosal restitution. Cell Mol Life Sci 62, 2932–2938. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Horikawa K, Yamada Y, Matsuda T, Kobayashi K, Hashimoto M, Matsu‐ura T, Miyawaki A, Michikawa T, Mikoshiba K & Nagai T (2010). Spontaneous network activity visualized by ultrasensitive Ca2+ indicators, yellow Cameleon‐Nano. Nat Methods 7, 729–732. [DOI] [PubMed] [Google Scholar]
- Hurst JH, Mumaw J, Machacek DW, Sturkie C, Callihan P, Stice SL & Hooks SB (2008). Human neural progenitors express functional lysophospholipid receptors that regulate cell growth and morphology. BMC Neurosci 9, 118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Iwatsubo T, Yamazaki M, Sugiyama Y, Suzuki H, Yanai S, Kim DC, Satoh H, Miyamoto Y, Iga T & Hanano M (1989). Epidermal growth factor as a regulatory hormone maintaining a low pH microclimate in the rat small intestine. J Pharm Sci 78, 457–459. [DOI] [PubMed] [Google Scholar]
- Kim YW, Lee WH, Choi SM, Seo YY, Ahn BO, Kim SH & Kim SG (2012). DA6034 promotes gastric epithelial cell migration and wound‐healing through the mTOR pathway. J Gastroenterol Hepatol 27, 397–405. [DOI] [PubMed] [Google Scholar]
- Kinoshita K, Taupin DR, Itoh H & Podolsky DK (2000). Distinct pathways of cell migration and antiapoptotic response to epithelial injury: structure‐function analysis of human intestinal trefoil factor. Mol Cell Biol 20, 4680–4690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Konturek PC, Brzozowski T, Pierzchalski P, Kwiecien S, Pajdo R, Hahn E & Konturek S (1998). Activation of genes for spasmolytic peptide, transforming growth factor alpha and for cyclooxygenase (COX)‐1 and COX‐2 during gastric adaptation to aspirin damage in rats. Aliment Pharmacol Ther 12, 767–778. [DOI] [PubMed] [Google Scholar]
- Koo MW (1994). The effects of milk and calcium on ethanol‐induced gastric mucosal damage. Pharmacol Res 29, 217–224. [DOI] [PubMed] [Google Scholar]
- Kosriwong K, Menheniott TR, Giraud AS, Jearanaikoon P, Sripa B & Limpaiboon T (2011). Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma. World J Gastroenterol 17, 1631–1641. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lacy ER & Ito S (1984). Rapid epithelial restitution of the rat gastric mucosa after ethanol injury. Lab Invest 51, 573–583. [PubMed] [Google Scholar]
- Lefebvre O, Wolf C, Kedinger M, Chenard MP, Tomasetto C, Chambon P & Rio MC (1993). The mouse one P‐domain (pS2) and two P‐domain (mSP) genes exhibit distinct patterns of expression. J Cell Biol 122, 191–198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- J Li, Yi H & Feng X‐p (2003). EGFR activates AP‐1 through ERK‐1/2 signaling pathway in the rat gastric mucosal cells. J Tradit Chin Med 9, 008. [Google Scholar]
- Mahe MM, Aihara E, Schumacher MA, Zavros Y, Montrose MH, Helmrath MA, Sato T & Shroyer NF (2013). Establishment of gastrointestinal epithelial organoids. Curr Protoc Mouse Biol 3, 217–240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Menard D & Pothier P (1991). Radioautographic localization of epidermal growth factor receptors in human fetal gut. Gastroenterology 101, 640–649. [DOI] [PubMed] [Google Scholar]
- Mori S, Morishita Y, Sakai K, Kurimoto S, Okamoto M, Kawamoto T & Kuroki T (1987). Electron microscopic evidence for epidermal growth factor receptor (EGF‐R)‐like immunoreactivity associated with the basolateral surface of gastric parietal cells. Acta Pathol Jpn 37, 1909–1917. [DOI] [PubMed] [Google Scholar]
- Muthusamy S, Shukla S, Amin MR, Cheng M, Orenuga T, Dudeja PK & Malakooti J (2012). PKCdelta‐dependent activation of ERK1/2 leads to upregulation of the human NHE2 transcriptional activity in intestinal epithelial cell line C2BBe1. Am J Physiol Gastrointest Liver Physiol 302, G317–G325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nie SN, Qian XM, Wu XH, Yang SY, Tang WJ, Xu BH, Huang F, Lin X, Sun DY, Sun HC & Li ZS (2003). Role of TFF in healing of stress‐induced gastric lesions. World J Gastroenterol 9, 1772–1776. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Niv Y & Banic M (2014). Gastric barrier function and toxic damage. Dig Dis 32, 235–242. [DOI] [PubMed] [Google Scholar]
- Oshima Y, Imamura T, Shintani A, Kajiura‐Kobayashi H, Hibi T, Nagai T, Nonaka S & Nemoto T (2014). Ultrasensitive imaging of Ca2+ dynamics in pancreatic acinar cells of yellow cameleon‐nano transgenic mice. Int J Mol Sci 15, 19971–19986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Poulsen SS, Thulesen J, Christensen L, Nexo E & Thim L (1999). Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat. Gut 45, 516–522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ranta‐Knuuttila T, Kiviluoto T, Mustonen H, Puolakkainen P, Watanabe S, Sato N & Kivilaakso E (2002). Migration of primary cultured rabbit gastric epithelial cells requires intact protein kinase C and Ca2+/calmodulin activity. Dig Dis Sci 47, 1008–1014. [DOI] [PubMed] [Google Scholar]
- Rodrigues S, Attoub S, Nguyen QD, Bruyneel E, Rodrigue CM, Westley BR, May FE, Thim L, Mareel M, Emami S & Gespach C (2003). Selective abrogation of the proinvasive activity of the trefoil peptides pS2 and spasmolytic polypeptide by disruption of the EGF receptor signaling pathways in kidney and colonic cancer cells. Oncogene 22, 4488–4497. [DOI] [PubMed] [Google Scholar]
- Rutten MJ & Ito S (1983). Morphology and electrophysiology of guinea pig gastric mucosal repair in vitro. Am J Physiol Gastrointest Liver Physiol 244, G171–G182. [DOI] [PubMed] [Google Scholar]
- Schlaermann P, Toelle B, Berger H, Schmidt SC, Glanemann M, Ordemann J, Bartfeld S, Mollenkopf HJ & Meyer TF (2016). A novel human gastric primary cell culture system for modelling Helicobacter pylori infection in vitro. Gut 65, 202–213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schreiber R (2005). Ca2+ signaling, intracellular pH and cell volume in cell proliferation. J Membr Biol 205, 129–137. [DOI] [PubMed] [Google Scholar]
- Schultheis PJ, Clarke LL, Meneton P, Harline M, Boivin GP, Stemmermann G, Duffy JJ, Doetschman T, Miller ML & Shull GE (1998). Targeted disruption of the murine Na+/H+ exchanger isoform 2 gene causes reduced viability of gastric parietal cells and loss of net acid secretion. J Clin Invest 101, 1243–1253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schumacher MA, Aihara E, Feng R, Engevik A, Shroyer NF, Ottemann KM, Worrell RT, Montrose MH, Shivdasani RA & Zavros Y (2015a). The use of murine‐derived fundic organoids in studies of gastric physiology. J Physiol 593, 1809–1827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schumacher MA, Feng R, Aihara E, Engevik AC, Montrose MH, Ottemann KM & Zavros Y (2015b). Helicobacter pylori‐induced Sonic Hedgehog expression is regulated by NFkappaB pathway activation: the use of a novel in vitro model to study epithelial response to infection. Helicobacter 20, 19–28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Svanes K, Ito S, Takeuchi K & Silen W (1982). Restitution of the surface epithelium of the in vitro frog gastric mucosa after damage with hyperosmolar sodium chloride. Morphologic and physiologic characteristics. Gastroenterology 82, 1409–1426. [PubMed] [Google Scholar]
- Svanes K, Takeuchi K, Ito S & Silen W (1983). Effect of luminal pH and nutrient bicarbonate concentration on restitution after gastric surface cell injury. Surgery 94, 494–500. [PubMed] [Google Scholar]
- Takeuchi K, Kato S, Konaka A & Sugawa Y (1999). Luminal calcium in regulation of nitric oxide release and acid secretion in rat stomachs after damage. Dig Dis Sci 44, 515–522. [DOI] [PubMed] [Google Scholar]
- Takeuchi K, Nobuhara Y & Okabe S (1985). Role of luminal Ca2+ on normal and damaged gastric mucosa in the rat. Dig Dis Sci 30, 1072–1078. [DOI] [PubMed] [Google Scholar]
- Tarnawski AS & Ahluwalia A (2012). Molecular mechanisms of epithelial regeneration and neovascularization during healing of gastric and esophageal ulcers. Curr Med Chem 19, 16–27. [DOI] [PubMed] [Google Scholar]
- Tarnawski AS & Jones MK (1998). The role of epidermal growth factor (EGF) and its receptor in mucosal protection, adaptation to injury, and ulcer healing: involvement of EGF‐R signal transduction pathways. J Clin Gastroenterol 27 (Suppl 1), S12–S20. [DOI] [PubMed] [Google Scholar]
- Taupin D & Podolsky DK (2003). Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 4, 721–732. [DOI] [PubMed] [Google Scholar]
- Vexler ZS, Symons M & Barber DL (1996). Activation of Na+‐H+ exchange is necessary for RhoA‐induced stress fiber formation. J Biol Chem 271, 22281–22284. [DOI] [PubMed] [Google Scholar]
- Wang J, Zhang J, Wu J, Luo D, Su K, Shi W, Liu J, Tian Y & Wei L (2012). MicroRNA‐610 inhibits the migration and invasion of gastric cancer cells by suppressing the expression of vasodilator‐stimulated phosphoprotein. Eur J Cancer 48, 1904–1913. [DOI] [PubMed] [Google Scholar]
- Wei C, Wang X, Chen M, Ouyang K, Song L‐S & Cheng H (2008). Calcium flickers steer cell migration. Nature 457, 901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wright NA, Pike C & Elia G (1990). Induction of a novel epidermal growth factor‐secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 343, 82–85. [DOI] [PubMed] [Google Scholar]
- Xie R, Xu J, Y‐f Xiao, Wu J, Wan H, Tang B, Liu J, Fan Y, Wang S‐M & Wu Y‐Y (2017). Calcium promotes human gastric cancer via a novel coupling of calcium‐sensing receptor and TRPV4 channel. Cancer Res, 77, 6499–6512. [DOI] [PubMed] [Google Scholar]
- Xu Q, Chen MY, He CY, Sun LP & Yuan Y (2013). Promoter polymorphisms in trefoil factor 2 and trefoil factor 3 genes and susceptibility to gastric cancer and atrophic gastritis among Chinese population. Gene 529, 104–112. [DOI] [PubMed] [Google Scholar]
- Xue L, Aihara E, Podolsky DK, Wang TC & Montrose MH (2010). In vivo action of trefoil factor 2 (TFF2) to speed gastric repair is independent of cyclooxygenase. Gut 59, 1184–1191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xue L, Aihara E, Wang TC & Montrose MH (2011). Trefoil factor 2 requires Na/H exchanger 2 activity to enhance mouse gastric epithelial repair. J Biol Chem 286, 38375–38382. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yanaka A, Suzuki H, Shibahara T, Matsui H, Nakahara A & Tanaka N (2002). EGF promotes gastric mucosal restitution by activating Na(+)/H(+) exchange of epithelial cells. Am J Physiol Gastrointest Liver Physiol 282, G866–G876. [DOI] [PubMed] [Google Scholar]
- Yang Z‐B, Yan J, Zou X‐P, Yi S‐X, Chang X‐R, Lin Y‐P & Li X‐P (2006). Enhanced expression of epidermal growth factor receptor gene in gastric mucosal cells by the serum derived from rats treated with electroacupuncture at stomach meridian acupoints. World J Gastroenterol 12, 5557. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yoo BK, He P, Lee SJ & Yun CC (2011). Lysophosphatidic acid 5 receptor induces activation of Na(+)/H(+) exchanger 3 via apical epidermal growth factor receptor in intestinal epithelial cells. Am J Physiol Cell Physiol 301, C1008–C1016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yu G, Zhang Y, Xiang Y, Jiang P, Chen Z & Lee W (2010). Cell migration‐promoting and apoptosis‐inhibiting activities of Bm‐TFF2 require distinct structure basis. Biochem Biophys Res Commun 400, 724–728. [DOI] [PubMed] [Google Scholar]
- Zimmerman NP, Vongsa RA, Faherty SL, Salzman NH & Dwinell MB (2011). Targeted intestinal epithelial deletion of the chemokine receptor CXCR4 reveals important roles for extracellular‐regulated kinase‐1/2 in restitution. Lab Invest 91, 1040. [DOI] [PMC free article] [PubMed] [Google Scholar]
